This course has expired. View available courses.
Endocrinology
Individualizing Antihyperglycemic Agents in Type 2 Diabetes
In this program we discuss the determination of how specific patient factors can help with the individualization of antihyperglycemic therapies.
DURATION
15 mins
PROFESSION
Physician
# OF CREDITS
0.25
ACCREDITATION
Mainpro+
EXPIRY DATE
2020-10-10
In this program
we discuss the determination of how specific patient factors can help with the
individualization of antihyperglycemic therapies.
Faculty
Peter Lin, MD, CCFP
David C.W. Lau, MD, PhD, FRCPC
Thomas Round, MBBS, BSc, DRCOG, MRCGP
David Strain, MB, ChB, BSc (Hons) MD, FRCP
Elizabeth Rosolowsky, MD, MPH, FAAP, FRCPC
Robyn L. Houlden, MD, FRCPC
John Axler, MD, CCFP, FCFP
Deanna Telner, MD, MEd, CCFP, FCFP
Jeffrey Habert, MD, CCFP, FCFP